NORCROSS, Ga.--(BUSINESS WIRE)--Auriga Laboratories, Inc. (OTCBB:ARGA), a specialty pharmaceutical company with products for the treatment of acute respiratory diseases and dermatological conditions, announces the launch of Aquoral™ for the treatment of xerostomia, also known as “dry mouth.” This new, patent-pending, prescription-only product introduction marks Auriga’s entrance into the $1 billion xerostomia marketplace.
